HomeREGULATORY
REGULATORY

MHLW Sets Carcinogen Limits in ARBs after Valsartan Impurity Issue
(Nov.6.2018)

PAFSC’s drug safety panel meeting on Nov. 5
The Ministry of Health, Labor and Welfare (MHLW) has set limits for cancer-causing substances N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA) that could be contained in angiotensin receptor blockers (ARBs) in the wake of a valsartan API impurity issue ...
(LOG IN FOR FULL STORY)